Quantcast

Latest Xyrem Stories

2015-01-05 16:25:34

DUBLIN, Jan. 5, 2015 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 33(rd) Annual J.P.

2014-12-11 16:25:04

Expects to complete submission in the first half of 2015 DUBLIN, Dec.

2014-12-02 16:27:39

Trial Initiated in Response to a FDA Pediatric Written Request to Study Xyrem in Children and Adolescents DUBLIN, Dec.

2014-12-02 16:27:36

Posters Include an Epidemiological Measure of the Effectiveness Analysis of Defibrotide from a Phase 3 Trial in Severe Hepatic VOD, as well as Updates from an International Compassionate Use Program

2014-08-05 16:27:58

Company Reports Second Quarter 2014 Total Revenues of $291 Million, Driven by Strong Sales of Xyrem, Erwinaze and Defitelio DUBLIN, Aug.

2014-08-05 16:27:45

Jazz Pharmaceuticals owns worldwide rights to defibrotide DUBLIN, Aug.

2014-07-22 16:27:22

DUBLIN, July 22, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 second quarter financial results on Tuesday, August 5, 2014,

2014-07-02 08:27:01

Jazz Pharmaceuticals to own worldwide rights to defibrotide at closing DUBLIN, July 2, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company


Word of the Day
definiens
  • The word or words serving to define another word or expression, as in a dictionary entry.
The word 'definiens' comes from the Latin word 'definire', 'to define'.
Related